文献速递药物不良反应与药物警戒特殊人群用药

吗啡相关双侧感音神经性听力损失一例

Morphine-induced hearing loss.
PubMed 文献 · Am J Health Syst Pharm · 2016-01-01

本文报告一例52岁西班牙男性在口服吗啡剂量增至每日120 mg后第8天出现双侧耳鸣及突发感音神经性听力损失,停药后听力未恢复需助听器。Naranjo量表评定为「很可能」,提示高剂量口服吗啡可能致耳毒性。

要点

  • 口服吗啡增量至每日120 mg后第8天出现双侧耳鸣与感音神经性听力损失。
  • 排除布洛芬、对乙酰氨基酚、水杨酸盐及其他耳毒性药物等常见原因。
  • 停药后听力损失未完全恢复,需使用助听器,Naranjo评定为「很可能」。

核心结论

  • 52岁男性在接受高剂量口服硫酸吗啡后出现耳鸣和听力损失,停药后听力未完全恢复并需助听器。

研究设计与样本

  • 个案报告:一例52岁西班牙男性患者的药物不良反应病例描述。

主要发现

  • 听力损失在启动口服吗啡后第8天出现,吗啡剂量递增至每日120 mg。
  • 未发现其他可能原因;脑磁共振排除其他听力损失病因。
  • 患者仅接受3剂布洛芬600 mg且未用对乙酰氨基酚,未使用水杨酸盐产品,其他药物无耳毒性不良反应。
  • 停药后听力损失未恢复,需使用助听器;Naranjo量表评定为「很可能」。

关键数值与推荐

  • Naranjo等药物不良反应概率量表评定该事件为「很可能」(probable)。

临床怎么用

  • 临床使用高剂量口服吗啡时应警惕耳鸣和听力损失等耳毒性表现。
  • 出现听力症状时应评估用药史并考虑停用可疑药物,但停药后听力可能不完全恢复。

局限性

  • 单个病例报告,因果关系评估基于Naranjo量表,不能确立因果关系。
  • 原文未报告听力检查的具体类型和结果细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: A case of severe bilateral sensorineural hearing loss associated with oral morphine is reported. SUMMARY: A 52-year-old Spanish man was admitted to the intensive care unit with a Glasgow Coma Scale score of 3, a fever, and sudden hearing loss with tinnitus in both ears. His medical history included type 2 diabetes mellitus, depression, sleep disorder, and hypertension. The patient also had pyelonephritis in 2011 and pulmonary embolism in 2014, requiring the placement of an inferior vena cava filter and chronic anticoagulation. His hearing loss appeared after the initiation of oral morphine, specifically on the eighth day of treatment, with increasing dosages of up to 120 mg daily. We did not find any other possible causes of the hearing loss. Ototoxicity is an adverse reaction of ibuprofen and acetaminophen, but the patient received only three doses of ibuprofen 600 mg and did not require acetaminophen. The patient's other medications did not have ototoxicity as an adverse reaction, and the patient confirmed not to have received any salicylate product. Brain magnetic resonance imaging discarded other possible causes of hearing loss. Our patient's hearing loss did not resolve after opioid discontinuation, and the use of hearing aids was necessary. According to the Naranjo et al. adverse drug reaction probability scale, this event would be classified as "probable." CONCLUSION: A 52-year-old man developed tinnitus and hearing loss after receiving high doses of oral morphine sulfate. His hearing loss did not fully resolve after the discontinuation of morphine, and he required the use of hearing aids.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Leache L, Aquerreta I, Moraza L, et al. Morphine-induced hearing loss. Am J Health Syst Pharm. 2016. PMID: 27821396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。